DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,126 filers reported holding DANAHER CORPORATION in Q2 2017. The put-call ratio across all filers is 0.51 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1 | -99.9% | 5 | +25.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 4 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -100.0% | 4 | -100.0% | 0.00% | -100.0% |
| Q1 2022 | $6,274,000 | -6.9% | 21,388 | +4.4% | 0.25% | +19.3% |
| Q4 2021 | $6,742,000 | +4.9% | 20,490 | -3.0% | 0.21% | -0.5% |
| Q3 2021 | $6,429,000 | +13.5% | 21,113 | 0.0% | 0.21% | +10.1% |
| Q2 2021 | $5,664,000 | +12.8% | 21,113 | -5.4% | 0.19% | +6.2% |
| Q1 2021 | $5,023,000 | -8.9% | 22,313 | -10.1% | 0.18% | -5.3% |
| Q4 2020 | $5,513,000 | +275550.0% | 24,823 | +225563.6% | 0.19% | – |
| Q3 2020 | $2,000 | +100.0% | 11 | +175.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 4 | -42.9% | 0.00% | – |
| Q1 2020 | $1,000 | 0.0% | 7 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | -99.6% | 7 | -99.6% | 0.00% | -100.0% |
| Q3 2019 | $267,000 | +1.5% | 1,845 | +0.3% | 0.01% | 0.0% |
| Q2 2019 | $263,000 | +4.4% | 1,839 | -3.7% | 0.01% | +20.0% |
| Q1 2019 | $252,000 | +31.9% | 1,909 | +3.0% | 0.01% | +25.0% |
| Q4 2018 | $191,000 | +3.8% | 1,853 | +9.6% | 0.00% | +33.3% |
| Q3 2018 | $184,000 | +10.2% | 1,691 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $167,000 | -4.6% | 1,691 | -5.4% | 0.00% | 0.0% |
| Q1 2018 | $175,000 | -0.6% | 1,788 | -5.6% | 0.00% | 0.0% |
| Q4 2017 | $176,000 | +18.9% | 1,894 | +9.5% | 0.00% | 0.0% |
| Q3 2017 | $148,000 | -2.6% | 1,730 | -3.8% | 0.00% | -25.0% |
| Q2 2017 | $152,000 | -3.2% | 1,798 | -2.0% | 0.00% | 0.0% |
| Q1 2017 | $157,000 | -98.0% | 1,835 | -98.5% | 0.00% | -98.8% |
| Q2 2013 | $7,664,000 | – | 121,074 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |